Prelude Capital Management’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Prelude Capital Management’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-167,339	Closed	-$6.02M	–	1683
2022 Q4	$6.02M	Buy	+167,339	New	+$4.18M	0.31%	58

Prelude Capital Management's IMGO Position: Q1 2023 in Review

Prelude Capital Management sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 167,339 shares — an estimated $6.02M sold.

Prelude Capital Management first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $6.02M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Prelude Capital Management reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Prelude Capital Management sold 167,339 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $6.02M.
Prelude Capital Management first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
Prelude Capital Management's Imago BioSciences, Inc. Common stock position peaked at $6.02M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.